Efficacy of olaparib combined to metronomic cyclophosphamide and metformin in patients with recurrent advanced/metastatic endometrial by molecular subtypes: ENDOLA phase I/II trial. Time course of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results